Psychedelic Integration Clinical Consultation Group

The goal of this group is to provide a safe, informative and confidential place for therapists and other practitioners to discuss their clinical work in psychedelic integration. This group will meet weekly for 12 weeks, and will keep the same members for the 12-week period. We will be learning the principles of Psychedelic Integration and methods for working with psychedelic experiences into ongoing psychotherapies. Members will be asked to present case material from their own practices once or twice during the group, and guided discussion will be encouraged. This group will be a supportive environment with the same confidentiality parameters as a psychotherapy group, and invites personal sharing, but is not a venue for therapists to discuss underground work with psychedelics that they may have done as a therapist. The group is open to practicing, licensed clinicians of all persuasions, but will emphasize psychological and psychodynamic perspectives, including discussions of transference and countertransference. We are asking CCG members to commit 12 week's participation upon registration; it is not a drop-in group.

Learning Objectives

At the end of the program, participants will be better able to...

1. Assess and reflect on the motivations for which patients seek Psychedelic Integration Therapy
2. Assess and verbalize the complex motivations of patients to seek out and use psychedelics
3. Rate the variety of subjective experiences and emotions patients report with psychedelics with nonjudgmental curiosity
4. Describe and acknowledge therapist reactions to patients who are seeking psychedelic experiences
5. Rate in equal esteem psychedelic experiences that are thoughtful and growth oriented and ones that are recreational, spontaneous, or dissociative
6. Assess and articulate how psychedelics can amplify transference
7. Assess and articulate how transferences to psychedelics can become fused with therapist transferences
8. Prepare for shifts in language, meaning, and self-concept that may accompany experiences with psychedelics
9. Explain openly (in appropriate settings) about emotional responses (countertransference) to patient reports as they relate to the therapist’s own relationship to psychedelic therapy
10. Describe states of psychic disruption that suggest a need for more intensive treatment
11. Describe extended support services for the patient, including family or community resources
12. Plan the guidance and support of non-drug self-transformation efforts as part of Psychedelic Integration Therapy